Amelioration of epidermolysis bullosa by transfer of wild-type bone marrow cells
about
Inherited epidermolysis bullosaMolecular therapeutics for heritable skin diseasesAdvances in understanding and treating dystrophic epidermolysis bullosaOne goal, different strategies--molecular and cellular approaches for the treatment of inherited skin fragility disordersDystrophic epidermolysis bullosa: a reviewCell therapy in dermatology.Mechanisms of fibroblast cell therapy for dystrophic epidermolysis bullosa: high stability of collagen VII favors long-term skin integrityRaising Awareness Among Healthcare Providers about Epidermolysis Bullosa and Advancing Toward a Cure.Bone marrow transplantation restores epidermal basement membrane protein expression and rescues epidermolysis bullosa model mice.Induced pluripotent stem cells from individuals with recessive dystrophic epidermolysis bullosa.Bone marrow transplantation for recessive dystrophic epidermolysis bullosaPharmacological mobilization of endogenous stem cells significantly promotes skin regeneration after full-thickness excision: the synergistic activity of AMD3100 and tacrolimus.Induced pluripotent stem cells in dermatology: potentials, advances, and limitationsA mouse model of generalized non-Herlitz junctional epidermolysis bullosa.Hematopoietic differentiation of induced pluripotent stem cells from patients with mucopolysaccharidosis type I (Hurler syndrome)PDGFRalpha-positive cells in bone marrow are mobilized by high mobility group box 1 (HMGB1) to regenerate injured epithelia.Mesenchymal stromal cells for treatment of steroid-refractory GvHD: a review of the literature and two pediatric cases.Placenta-based therapies for the treatment of epidermolysis bullosaPreconditioning of mesenchymal stem cells for improved transplantation efficacy in recessive dystrophic epidermolysis bullosaImmunogenicity of decidual stromal cells in an epidermolysis bullosa patient and in allogeneic hematopoietic stem cell transplantation patientsGene editing toward the use of autologous therapies in recessive dystrophic epidermolysis bullosa.Novel molecular therapies for heritable skin disordersAnimal models of skin disease for drug discovery.From marrow to matrix: novel gene and cell therapies for epidermolysis bullosa.From Mesoderm to Mesodermatology: Bone Marrow Mesenchymal Cells Heal Skin Wounds.Hematopoietic stem cells are pluripotent and not just "hematopoietic".TALEN-based gene correction for epidermolysis bullosa.Immune regulatory cells in umbilical cord blood: T regulatory cells and mesenchymal stromal cells.Allogeneic blood and bone marrow cells for the treatment of severe epidermolysis bullosa: repair of the extracellular matrix.Patient-specific naturally gene-reverted induced pluripotent stem cells in recessive dystrophic epidermolysis bullosaNovel and emerging therapies in the treatment of recessive dystrophic epidermolysis bullosa.Factors affecting quality of life in epidermolysis bullosa.Concise review: hitting the right spot with mesenchymal stromal cells.The umbilical cord: a rich and ethical stem cell source to advance regenerative medicine.Concise review: Transplantation of human hematopoietic cells for extracellular matrix protein deficiency in epidermolysis bullosa.Bone marrow transplantation in epidermolysis bullosa.The long and winding road that leads to a cure for epidermolysis bullosa.Gene therapy: pursuing restoration of dermal adhesion in recessive dystrophic epidermolysis bullosa.Therapies for inherited skin fragility disorders.Next generation human skin constructs as advanced tools for drug development.
P2860
Q21202884-E0176D62-44DF-4E6A-96A6-A6AC7AE79E56Q26865551-BA1BA244-DA17-42E7-8E7F-0D935B6D9A98Q27006669-3317A27D-92B3-4BC5-BE29-56BBC57CADF4Q27026711-05032899-5F0B-48E0-B351-F3294ADE6305Q28084871-F0B0D2BA-6FB2-42E7-8DC9-89E804C90ED4Q33653689-50A4320A-675F-493A-A5EC-BBD58DA890F6Q33713926-A8CD1CDB-0336-494A-A9B6-7C6CE3B556AAQ33821599-C9CA4D66-80E4-43A8-B636-B671663454C1Q34069632-4A8FDE7F-A61D-4D73-922B-DAD558B91276Q34120479-ED322945-E17E-4773-9345-4ED7C6A11F89Q34256616-A1CC7C4E-AADD-4F0E-8DFA-785790C305A0Q34328240-F3088E12-AC50-4B05-AB05-1C76AC7835A2Q34400271-26434D9E-EDA3-44C7-90C2-9B66B320C24DQ34441240-7DCD0BD7-1FE8-4CBD-83F6-1AEB2631F520Q34557967-F6CEDA18-1CFA-4D5A-B1E6-BD0CCAA92689Q34835916-6AC80674-E4E5-4A45-B45A-0A889B619686Q35203695-C12404B2-EA08-41F3-8FF4-5C76FA5B8900Q35582332-019EEDB4-7BA2-457F-913A-2E3F1D6CC9E8Q35655462-FB1EC237-2CA5-4AB2-884F-9267D9C1F346Q35797175-A920C9B4-914C-4B6F-B116-ABE0F1DF3101Q36326838-AC8E740F-DFE3-4F77-A203-3B53D3D9822FQ36610899-AA9C13DA-33C5-44A5-92C0-87A72B2FB73FQ36631641-557067D6-D170-43E7-820E-BD407AB2D76CQ36756725-9D0B4F80-C8BF-4A6C-AF59-384B0935FF24Q36757030-1F41DC76-566C-4B1F-B684-0377D665DB64Q36824005-4312F152-B7BE-48A5-BEC7-CFA6A580C2C2Q36915141-B414AD8F-DA7F-4237-9EC7-089A0D808520Q37606564-2E41D11D-227C-4BC5-AA7B-A8BF8364BF84Q37649276-0962A28F-8780-4A26-89CE-213E5DF8D2FFQ37707008-8CE55A88-53BB-4D24-BFB5-B7E24EE4971BQ37712686-F65EA350-F78D-4BBB-AE79-8D682A2B1177Q37764876-5144D007-5C25-4116-B547-0C2ECCA27AF3Q37769501-EFA5FB9A-6DF0-4F23-B1E8-754812E53345Q37863721-FA78F921-7860-45CA-9C93-978D57F70562Q37873887-575FE7D6-079C-4EF1-87BD-848147B3754FQ38067450-C6E95F2A-F211-4E65-8FBE-BDAA9418DBE9Q38119245-7633AE54-830D-45DB-A2EF-FF030969312CQ38150897-E58B869A-621C-4CD2-A391-93183C3FFC57Q38444460-968CD5B1-C053-4C40-B6EC-84497A6AD7C7Q38673576-A0EBC632-5578-476D-AD40-1C8D493754AE
P2860
Amelioration of epidermolysis bullosa by transfer of wild-type bone marrow cells
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Amelioration of epidermolysis bullosa by transfer of wild-type bone marrow cells
@en
Amelioration of epidermolysis bullosa by transfer of wild-type bone marrow cells.
@nl
type
label
Amelioration of epidermolysis bullosa by transfer of wild-type bone marrow cells
@en
Amelioration of epidermolysis bullosa by transfer of wild-type bone marrow cells.
@nl
prefLabel
Amelioration of epidermolysis bullosa by transfer of wild-type bone marrow cells
@en
Amelioration of epidermolysis bullosa by transfer of wild-type bone marrow cells.
@nl
P2093
P2860
P50
P1433
P1476
Amelioration of epidermolysis bullosa by transfer of wild-type bone marrow cells
@en
P2093
Angela M Christiano
Catherine Slattery
John E Wagner
Mark Osborn
Megan Riddle
Ron T McElmurry
P2860
P304
P356
10.1182/BLOOD-2008-06-161299
P407
P577
2008-10-27T00:00:00Z